HomeAI · summaries
Storia in 2 fonti
Treatment Intensification Slows Metastatic Hormone-Sensitive Prostate Cancer
Talazoparib plus enzalutamide reduces progression risk by 50% in men with DNA repair alterations
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
- ·
medpagetoday.com
Treatment Intensification Slows Metastatic Hormone-Sensitive Prostate Cancer
Talazoparib plus enzalutamide reduces progression risk by 50% in men with DNA repair alterations